Read our report on all things Molecular Diagnostics, including some great contributed articles. Need to know about liquid biopsies? Want to know what the current regulatory landscape looks like? Then you’ve come to the right place.
A small pilot study presented at the European Society for Human Reproduction and Embryology 2018, suggest that DNA shed from early embryos could one day provide an alternative way of genetically testing them without having to do a biopsy.
The US Health and Human Services Secretary Alex Azar has approved adding a test for spinal muscular atrophy to the list of recommended newborn screens in the United States.
Myriad Genetics has revealed it is acquiring genetic screening firm Counsyl for $375 million.
Beckman Coulter has announced FDA clearance of its automated Access AMH immunoassay for in vitro diagnostic (IVD) use in the U.S.
ACMG is developing a series of one-page documents to help guide doctors through discussing incidental findings and NIPT results with patients
Extending noninvasive prenatal screening to all 24 human chromosomes can detect genetic disorders that may explain miscarriage & abnormalities during pregnancy.
Research has shown that DNA-based prenatal blood tests can be offered appropriately and effectively to all women